Physician profile
Vincent E Lorenz
NPI 1700899887
$1,230.62
in general payments reported to CMS, 2019-2025
16 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $360 · 2022: $133 · 2023: $260 · 2024: $276 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $220.97 | 2021-2025 | Euflexxa |
| Pacira Therapeutics, INC. | $220.47 | 2021 | |
| Smith+Nephew, INC. | $193.76 | 2021-2024 | Healicoil, Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix |
| Abbott Laboratories | $87.83 | 2021-2025 | Axium, Proclaim |
| Bioventus LLC | $81.97 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Depuy Synthes Sales INC. | $81.06 | 2021-2024 | Monovisc, Orthovisc |
| Endo Pharmaceuticals INC. | $58.47 | 2021-2024 | Xiaflex |
| Averitas Pharma INC. | $47.66 | 2025 | Qutenza |
| Kowa Pharmaceuticals America, INC. | $41.23 | 2022 | |
| Fidia Pharma USA INC. | $36.18 | 2022-2025 | Triluron, Hymovis |
| Pacira Pharmaceuticals Incorporated | $34.82 | 2023 | Zilretta, Iovera, Exparel |
| Amgen INC. | $32.85 | 2024-2025 | Krystexxa, Prolia, Evenity |
| Zimmer Biomet Holdings, INC. | $29.29 | 2023 | Gel-One Cross-Linked Hyaluronate |
| Vericel Corporation | $28.41 | 2023 | Maci |
| Lundbeck LLC | $20.65 | 2025 | Vyepti |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $15.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Lorenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.